These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

810 related items for PubMed ID: 1973041

  • 21. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML, Graybiel AM, David JC, Robertson HA.
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [Abstract] [Full Text] [Related]

  • 22. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM, Kelley AE.
    Neuroscience; 1990 Oct; 39(1):59-67. PubMed ID: 1982467
    [Abstract] [Full Text] [Related]

  • 23. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J, Bøgesø KP, Hyttel J, Meier E.
    Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
    [Abstract] [Full Text] [Related]

  • 24. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ.
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [Abstract] [Full Text] [Related]

  • 25. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW, Qin ZH, Weiss B.
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [Abstract] [Full Text] [Related]

  • 26. D1 and D2 receptors and circling behavior in rats with unilateral lesion of the entopeduncular nucleus.
    Pazo JH, Murer GM, Segal E.
    Brain Res Bull; 1993 Jan; 30(5-6):635-9. PubMed ID: 8096164
    [Abstract] [Full Text] [Related]

  • 27. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
    Löschmann PA, Smith LA, Lange KW, Jaehnig P, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1991 Jan; 105(3):303-9. PubMed ID: 1686813
    [Abstract] [Full Text] [Related]

  • 28. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L.
    Synapse; 1990 Jan; 5(2):113-9. PubMed ID: 2137942
    [Abstract] [Full Text] [Related]

  • 29. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G, Demenge P.
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [Abstract] [Full Text] [Related]

  • 30. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK, McGinty JF, Hong JS.
    Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976
    [Abstract] [Full Text] [Related]

  • 31. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
    Koller WC, Herbster G.
    Clin Neuropharmacol; 1988 Jun 15; 11(3):221-31. PubMed ID: 3261198
    [Abstract] [Full Text] [Related]

  • 32. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep 15; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 33. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 15; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 34. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.
    Olsson M, Nikkhah G, Bentlage C, Björklund A.
    J Neurosci; 1995 May 15; 15(5 Pt 2):3863-75. PubMed ID: 7751951
    [Abstract] [Full Text] [Related]

  • 35. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
    Bordi F, Meller E.
    Brain Res; 1989 Dec 18; 504(2):276-83. PubMed ID: 2574622
    [Abstract] [Full Text] [Related]

  • 36. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H, Gerlach J, Peacock L.
    Clin Neuropharmacol; 1992 Dec 18; 15(6):448-58. PubMed ID: 1362136
    [Abstract] [Full Text] [Related]

  • 37. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE, Wooten GF.
    Brain Res Mol Brain Res; 1992 Jan 18; 12(1-3):111-9. PubMed ID: 1312196
    [Abstract] [Full Text] [Related]

  • 38. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS, Robertson HA.
    Brain Res; 1986 Oct 08; 384(2):387-90. PubMed ID: 2946360
    [Abstract] [Full Text] [Related]

  • 39. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ, Marshall JF.
    Neuroscience; 1991 Oct 08; 41(2-3):473-81. PubMed ID: 1678501
    [Abstract] [Full Text] [Related]

  • 40. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.